AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • May 18th, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledMay 18th, 2020 Industry Jurisdiction
AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • March 2nd, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledMarch 2nd, 2020 Industry Jurisdiction
AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • January 21st, 2020 • Biological products, (no disgnostic substances) • New York
Company FiledJanuary 21st, 2020 Industry Jurisdiction
AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • December 31st, 2018 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 31st, 2018 Industry Jurisdiction
AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • December 29th, 2017 • Biological products, (no disgnostic substances) • New York
Company FiledDecember 29th, 2017 Industry Jurisdiction